Showing results (311-320 of 372) with videos related to
Sort By:
Pageof 38
Annals of the Rheumatic Diseases|June 6, 2009
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritisAstrid Jüngel, Caroline Ospelt, Mark Lesch, et al.Biochemistry|January 25, 1994
The role of lysine 166 in the mechanism of mandelate racemase from Pseudomonas putida: mechanistic and crystallographic evidence for stereospecific alkylation by (R)-alpha-phenylglycidateJ A Landro, J A Gerlt, J W Kozarich, et al.Arthritis and Rheumatism|October 15, 2003
Galectin 3 and its binding protein in rheumatoid arthritisShiro Ohshima, Stefan Kuchen, Christian A Seemayer, et al.Experimental & Molecular Medicine|January 11, 2024
The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseasesTeresa R Kee, Sophia A Khan, Maya B Neidhart, et al.Leukemia|March 31, 1998
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'AdulteP Brice, D Cazals, N Mounier, et al.Journal of the National Cancer Institute|August 17, 1991
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group studyJ D Cowan, J Neidhart, S McClure, et al.Science (New York, N.Y.)|August 3, 1990
Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 proteaseJ Erickson, D J Neidhart, J VanDrie, et al.Osteoarthritis and Cartilage|May 12, 2000
Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runnersM Neidhart, U Müller-Ladner, W Frey, et al.The Journal of Experimental Medicine|December 6, 2000
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cellsF Berard, P Blanco, J Davoust, et al.Chimia|May 10, 2017
Challenges and Rewards in Medicinal Chemistry Targeting Cardiovascular and Metabolic DiseasesWerner Neidhart, Jean Ackermann, Kurt Amrein, et al.Pageof 38